Physicians

This material provides sputum collection tips for healthcare workers to be aware of before, during, and after collection.

This handout describes nontuberculous mycobacteria (NTM), clinical manifestations, NTM diagnosis, treatment, and action required. The handout also includes 2019 data from the Virginia Department of Health TB Program and links to additional information.

This 90-minute webinar focuses on how anti-black racism impacts African Americans' access to care and the quality of care they receive. The webinar also includes information on specific strategies for clinicians and programs to consider to improve TB care for African American patients.

This clinical bulletin provides information on testing for and treating latent TB information. The bulletin also includes resources for providers, resources for patients, and more! 

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.

This guideline compiles up-to-date legal requirements across all U.S. states and territories, clarifying when healthcare providers and laboratories must report negative Hepatitis C test outcomes. It offers a clear, state-by-state breakdown to help public health entities and providers comply with surveillance obligations and improve data completeness.

This guideline presents a comprehensive state-by-state legal analysis of obligations for healthcare providers and laboratories to report negative HIV test outcomes. It clearly highlights jurisdictional differences, helping public health officials and clinicians ensure compliance with surveillance mandates and improve disease tracking.

GLP-1 receptor agonists (GLP-1s), including semaglutide, tirzepatide, and liraglutide, are increasingly used for weight management and show promise for people living with HIV (PLWH). While these medications are generally safe, PLWH may face additional considerations when using them due to how GLP-1s function and interact with antiretroviral therapy (ART). GLP-1s slow gastric emptying and suppress appetite, which may affect ART absorption; gastrointestinal side effects such as nausea or vomiting may also interfere with consistent ART dosing.

This infographic from Fair Health draws on data from its NPIC database—over 47 billion commercial medical and dental claims—to highlight rising trends in sexually transmitted disease (STD) diagnoses across various demographics in the U.S. between 2020 and 2023. The visuals show that overall STD diagnoses increased significantly, led by notable rises in syphilis, gonorrhea, and HIV/AIDS.

Tuberculosis (TB) remains the world’s deadliest infectious disease and a major treatment challenge, especially in cases resistant to standard therapies. A new AI-powered tool developed by Tufts University researchers, called DECIPHAER (Decoding Cross-Modal Information of Pharmacologies via Autoencoders), seeks to advance TB treatment by elucidating exactly how drugs kill the bacterium at the cellular and molecular levels.